Higher doses of cabergoline further improve metabolic parameters in patients with prolactinoma regardless of the degree of reduction in prolactin levels.

Research output: Contribution to journalArticlepeer-review

46 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Higher doses of cabergoline further improve metabolic parameters in patients with prolactinoma regardless of the degree of reduction in prolactin levels.'. Together they form a unique fingerprint.

Medicine & Life Sciences